| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/23/2003 | EP1100482B1 Use of calix(n)arenes in the manufacture of a medicament for treating fibrotic diseases |
| 07/23/2003 | EP1086096B1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors |
| 07/23/2003 | EP1079829B1 Use of benzofuroxan derivatives in treating angina pectoris |
| 07/23/2003 | EP1079818B1 Composition comprising il-18 and topotecan for treatment and/or prevention of cancer |
| 07/23/2003 | EP1075259B1 Novel fatty analogues for the treatment of diabetes |
| 07/23/2003 | EP1056742B1 Anti-viral pyrimidine derivatives |
| 07/23/2003 | EP1053012B1 Pharmaceutical compositions comprising peg-asparaginase for the treatment of hiv infections |
| 07/23/2003 | EP1035842A4 IMPROVED HMG CoA REDUCTASE INHIBITOR EXTENDED RELEASE FORMULATION |
| 07/23/2003 | EP1032575B1 2,3-diaryl-pyrazolo(1,5-b)pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors |
| 07/23/2003 | EP1025083B1 Process for stereoselective synthesis of prostacyclin derivatives |
| 07/23/2003 | EP1015452B1 Optionally protected 3-hydroxymethyl carbapenems and synthesis |
| 07/23/2003 | EP1007024B1 Delayed-release dosage forms of sertraline |
| 07/23/2003 | EP1001957B1 Macrolides with antitumor activity |
| 07/23/2003 | EP0975636B1 1h-pyrazolo[3,4-d]pyrimidine-4,6-diones as t-cell proliferation inhibitors |
| 07/23/2003 | EP0969849B1 Stable solid preparation containing vitamin d3 and tricalcium phosphate |
| 07/23/2003 | EP0961613A4 Methods and compositions for the treatment of bone resorption disorders, including osteoporosis |
| 07/23/2003 | EP0942724B1 Gel formulations for topical drug delivery |
| 07/23/2003 | EP0930831B1 Flavonol containing food supplements |
| 07/23/2003 | EP0929528B1 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 07/23/2003 | EP0920323B1 Novel use of phospholipids of animal origin in therapy and/or dietetics |
| 07/23/2003 | EP0914166B1 Methods of terminal sterilization of biological products |
| 07/23/2003 | EP0914133B1 Use of hyaluronan (ha) for cell mobilization |
| 07/23/2003 | EP0898559B1 Cytoprotective compounds |
| 07/23/2003 | EP0888278B1 Antidiabetic agents |
| 07/23/2003 | EP0858319B1 Use of carboxylic acids having a sulphur function for promoting skin exfoliation or stimulating epidermal regeneration |
| 07/23/2003 | EP0855919B1 Induction of mucosal immune responses by vitamin d3 and antigen-encoding dna complexe to cationic lipid |
| 07/23/2003 | EP0838223B1 Brain edema inhibitor |
| 07/23/2003 | EP0822817B1 Use of (r)-penciclovir triphosphate for the manufacture of a medicament for the treatment of viral diseases |
| 07/23/2003 | EP0820290B1 Use of vitamin d 2 or vitamin d 4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism |
| 07/23/2003 | EP0811011B1 Carbohydrate conjugated bio-active compounds |
| 07/23/2003 | EP0808163B1 Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts |
| 07/23/2003 | EP0804411B1 Synthetic polyunsaturated fatty acid analogues |
| 07/23/2003 | EP0695183B1 Use of thiazolidinediones for the treatment of atherosclerosis and eating disorders |
| 07/23/2003 | EP0628044B1 Therapeutic nucleosides |
| 07/23/2003 | EP0628033B1 Benzodiazepin derivatives useful as cck-receptor antagonists |
| 07/23/2003 | CN1432068A Methods for ansamitocin prodn. method |
| 07/23/2003 | CN1432063A Humanised antibodies to epidermal growth factor receptor |
| 07/23/2003 | CN1432022A Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties |
| 07/23/2003 | CN1432020A 嘌呤衍生物 Purine derivatives |
| 07/23/2003 | CN1432019A Hygromycin derivatives for treatment of bacterial and protozoal infections |
| 07/23/2003 | CN1432018A Crystalline and amorphous form of triazolo (4,5-d) pyrimidine compound |
| 07/23/2003 | CN1432015A Indazoles substituted with 1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation |
| 07/23/2003 | CN1432014A Triazole compounds having amide linkage |
| 07/23/2003 | CN1432012A Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain |
| 07/23/2003 | CN1432011A Benzoamide piperidine compounds as substance P antagonists |
| 07/23/2003 | CN1432010A 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroi-soquinol-2-yl)-5-(2-pyridyl) quinazo line mesylat and polymorphs |
| 07/23/2003 | CN1432009A Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain |
| 07/23/2003 | CN1432008A Quinolonecarboxylic acid derivative |
| 07/23/2003 | CN1432007A Inhibitors of alpha L beta 2 mediated cell adhesion |
| 07/23/2003 | CN1432004A Alkynyl phenyl heteroaromatic glucokinase activators |
| 07/23/2003 | CN1432001A 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
| 07/23/2003 | CN1432000A TNF-alpha prodn. inhibitors |
| 07/23/2003 | CN1431999A Indole derivatives with vascular damagine activity |
| 07/23/2003 | CN1431998A Growth hormone secretagogues |
| 07/23/2003 | CN1431997A 2-acyl indol derivatives and their use as anti-tumour agents |
| 07/23/2003 | CN1431995A Antipicornaviral compounds and compsns. their pharmaceutical uses, and materials for their synthesis |
| 07/23/2003 | CN1431964A Methods of producing terminally sterilized topical patch preparation |
| 07/23/2003 | CN1431941A 挤压模 Extrusion die |
| 07/23/2003 | CN1431916A Oral delivery method and compsn. for solid medications or dietary supplements |
| 07/23/2003 | CN1431915A Treatment of congestive heart failure with compsn. comprising diuretic agent and vasopressin antagonist |
| 07/23/2003 | CN1431914A Ectocornea extension promoters |
| 07/23/2003 | CN1431910A Ginsenoside chemotherapy |
| 07/23/2003 | CN1431909A Combinations for treating neoplasms |
| 07/23/2003 | CN1431908A Kits and methods for optimizing efficacy of chondroprotective compsns. |
| 07/23/2003 | CN1431907A Method of treating hepatitis delta viral infection |
| 07/23/2003 | CN1431906A Percutaneous absorption type steroid prepn. for external use |
| 07/23/2003 | CN1431905A Use of fulvestrant in treatment of resistant breast cancer |
| 07/23/2003 | CN1431904A Protease inhitors |
| 07/23/2003 | CN1431903A Minoxidil-containing preparations |
| 07/23/2003 | CN1431902A Therapeutic combinations of antihypertensive and antiangiogenic agents |
| 07/23/2003 | CN1431901A S-methyl-dihydro-zipprasidone for treatment of psychiatric and ocular disorders |
| 07/23/2003 | CN1431900A Methods and compsns. useful in enhancing oxygon delivery to cells |
| 07/23/2003 | CN1431899A Pharmaceutical combination of bicalutamide and tamoxifen for providing anti-androgenic effect and anti-oestrogenic effect |
| 07/23/2003 | CN1431898A Methods of use of penicillamines for treatment of conditions resulting from DNA damage |
| 07/23/2003 | CN1431897A Peptide deformylase inhibitors |
| 07/23/2003 | CN1431896A Oily compsns. contg. highly fat-soluble drugs |
| 07/23/2003 | CN1431895A Compsns-and methods for trapping and inactivating pathogenic microbes and spermatozoa |
| 07/23/2003 | CN1431228A Chitosam chromium, its preparing method and application |
| 07/23/2003 | CN1431221A Total saponin of polygara aureocauda dunn and madication combination as well as its preparing method |
| 07/23/2003 | CN1431217A Human angiogenin antisense oligonucleotide and medicine combination |
| 07/23/2003 | CN1431215A Method for preparing glucoside in resveratrol of medicine to nourish liver and lowering fat |
| 07/23/2003 | CN1431214A Technology for synthesizing polyester of cane sugar acids with high degree of esterification |
| 07/23/2003 | CN1431212A Similar of sulph DCK, its synthesizing method and applications |
| 07/23/2003 | CN1431211A Amine salt of cefathiamiding, its preparing method and application |
| 07/23/2003 | CN1431204A Method for preparing water-soluble soybean aglycon and its applications |
| 07/23/2003 | CN1431203A 7-substitution-1-hero hydrogenated-2-ketone and ramification as well as its synthesizing method and usage |
| 07/23/2003 | CN1431200A Compound of phycocyania of blue-green algae, its preparing method and usage |
| 07/23/2003 | CN1431197A Alanine class compound, its preparing method and use |
| 07/23/2003 | CN1431188A Method for preparing sea squirt fatty acids and methyl ester, ethyl ester, triglyceride and its preparing method as well as application infunctional food and drugs |
| 07/23/2003 | CN1431187A Kaurane type diterpene compound and its preparing method as well as application in anticancer drugs |
| 07/23/2003 | CN1431185A Method for preparing extractive of unsaturated fatty acid possessing function of lowering fat from camellia seeds |
| 07/23/2003 | CN1431007A Combination of external remedy for treating skin disease and venereal disease |
| 07/23/2003 | CN1431005A Product containing extractive of balsam pear and pumpkin possessing functions of reducing blood sugar and fat |
| 07/23/2003 | CN1430998A Drip pills for curing aphtha and its preparing method |
| 07/23/2003 | CN1430995A Formula for removing speckles as well as its preparing method |
| 07/23/2003 | CN1430994A Chinese medical prepn. for preventing and curing cardiovascular, cerebrovascular diseases and its prodn. method |
| 07/23/2003 | CN1430989A Ointment of Chinese herbal medicine for reactivating nerve and its mfg. method |
| 07/23/2003 | CN1430969A Combination of Chinese angelica polysaccharide and its preparing method |
| 07/23/2003 | CN1430968A Injection liquid of extractive gingko leaves and its preparing method |
| 07/23/2003 | CN1430967A Naringin used in preparing medicine for curing acute and chronic bronchitis |